Procter & Gamble Health Limited has announced that its Board of Directors will convene on May 26, 2026, to review the company's audited financial statements for the financial year ended March 31, 2026, and consider recommendations for final dividend distribution to shareholders.

Board Meeting Details

The healthcare company formally notified the stock exchanges about the upcoming board meeting through a regulatory filing dated March 27, 2026. The meeting has been scheduled in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Agenda Items

The board meeting will address two primary matters of significant importance to shareholders and stakeholders. The directors will deliberate on the audited financial statements for the financial year ended March 31, 2026, providing a comprehensive review of the company's financial performance during this period. Additionally, the board will evaluate and potentially recommend a final dividend distribution, subject to their assessment of the company's financial position and future requirements.

Regulatory Communication

The company has fulfilled its disclosure obligations by informing both major stock exchanges about the scheduled board meeting. The communication was sent to BSE Limited, where the company trades under scrip code 500126, and to the National Stock Exchange of India Limited, where it is listed under the symbol PGHL.

Company Leadership

The regulatory filing was signed by Zeal Rupani, who serves as the Company Secretary of Procter & Gamble Health Limited. The digital signature was authenticated on March 27, 2026, ensuring proper documentation and compliance with regulatory requirements for corporate communications.

Procter & Gamble Health Limited has declared an interim dividend of ₹160 per equity share, including a one-time special dividend of ₹50 per share, for Financial Year 2025-26. The Board of Directors approved this dividend declaration at their meeting held on February 6, 2026.

Dividend Declaration Details

The company's interim dividend announcement represents a significant return to shareholders, combining regular dividend payments with a special distribution. The dividend will be payable to eligible shareholders whose names appear in the Register of Members or in the records of Depositories as beneficial owners.

Tax Deduction Guidelines

The company has issued comprehensive guidelines regarding Tax Deduction at Source (TDS) on dividend payments, in accordance with the Income Tax Act, 1961 as amended by the Finance Act, 2020. Since April 1, 2020, dividends are taxable in shareholders' hands, requiring the company to deduct tax at source at applicable rates.

Resident Shareholders TDS Rates

Non-Resident Shareholders

Non-resident shareholders, including Foreign Institutional Investors (FII) and Foreign Portfolio Investors (FPI), will be subject to 20% TDS plus applicable surcharge and cess, or beneficial DTAA rates if eligible documentation is provided.

Compliance Requirements

Shareholders must submit required forms and documents by February 10, 2026, to avail appropriate TDS rates. The company will not consider incomplete, unsigned, or late submissions. TDS certificates will be emailed to registered email addresses, and shareholders can view TDS credits in Form 26AS through their e-filing accounts.

Shareholder Action Items

Shareholders holding shares in dematerialized mode should update their records with depositories through depository participants, while physical shareholders must provide details to the company's registrar, KFin Technologies Private Limited. Updated bank details are also required for electronic dividend distribution as per SEBI directives.